Lots of long COVID treatment leads, but few are proven
- PMID: 36048910
- PMCID: PMC9456722
- DOI: 10.1073/pnas.2213524119
Lots of long COVID treatment leads, but few are proven
Figures


Similar articles
-
COVID-19 long haulers.Nat Biotechnol. 2021 Aug;39(8):908-913. doi: 10.1038/s41587-021-00984-7. Nat Biotechnol. 2021. PMID: 34257426 Free PMC article.
-
Sulodexide: A Benefit for Cardiovascular Sequelae of Long COVID Patients?Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221084300. doi: 10.1177/10760296221084300. Clin Appl Thromb Hemost. 2022. PMID: 35333125 Free PMC article. No abstract available.
-
Long-COVID treatments: why the world is still waiting.Nature. 2022 Aug;608(7922):258-260. doi: 10.1038/d41586-022-02140-w. Nature. 2022. PMID: 35945375 No abstract available.
-
Therapeutic and prophylactic effect of flavonoids in post-COVID-19 therapy.Phytother Res. 2022 May;36(5):2042-2060. doi: 10.1002/ptr.7436. Epub 2022 Mar 18. Phytother Res. 2022. PMID: 35302260 Free PMC article. Review.
-
Venous Thromboembolic Disease in COVID-19, Pathophysiology, Therapy and Prophylaxis.Int J Mol Sci. 2022 Sep 8;23(18):10372. doi: 10.3390/ijms231810372. Int J Mol Sci. 2022. PMID: 36142282 Free PMC article. Review.
Cited by
-
The importance of patient-partnered research in addressing long COVID: Takeaways for biomedical research study design from the RECOVER Initiative's Mechanistic Pathways taskforce.Elife. 2023 Sep 22;12:e86043. doi: 10.7554/eLife.86043. Elife. 2023. PMID: 37737716 Free PMC article.
-
Modifiable lifestyle factors and the risk of post-COVID-19 multisystem sequelae, hospitalization, and death.Nat Commun. 2024 Jul 29;15(1):6363. doi: 10.1038/s41467-024-50495-7. Nat Commun. 2024. PMID: 39075060 Free PMC article.
-
Long COVID: Costs for the German economy and health care and pension system.BMC Health Serv Res. 2023 Jun 14;23(1):641. doi: 10.1186/s12913-023-09601-6. BMC Health Serv Res. 2023. PMID: 37316880 Free PMC article.
-
Mechanisms of long COVID: An updated review.Chin Med J Pulm Crit Care Med. 2023 Dec 6;1(4):231-240. doi: 10.1016/j.pccm.2023.10.003. eCollection 2023 Dec. Chin Med J Pulm Crit Care Med. 2023. PMID: 39171285 Free PMC article. Review.
-
Brain Leukocytes as the Potential Therapeutic Target for Post-COVID-19 Brain Fog.Neurochem Res. 2023 Aug;48(8):2345-2349. doi: 10.1007/s11064-023-03912-0. Epub 2023 Mar 23. Neurochem Res. 2023. PMID: 36952147 Free PMC article.
References
-
- Mahase E., Covid-19: What do we know about “long covid”? BMJ 370, m2815 (2020). - PubMed
-
- Bull-Otterson L., et al. , Post-COVID conditions among adult COVID-19 survivors aged 18–64 and ≥65 years — United States, March 2020–November 2021. MMWR Morb. Mortal. Wkly. Rep. 71, 713–717 (2022).
MeSH terms
LinkOut - more resources
Full Text Sources
Medical